• Explore /
  • Poster
  • / A phase I dose-escalation trial of intraperitoneal oxaliplatin with systemic capecitabine and bevacizumab following cytoreduction in patients with peritoneal carcinomatosis from appendiceal or colorectal cancer.

A phase I dose-escalation trial of intraperitoneal oxaliplatin with systemic capecitabine and bevacizumab following cytoreduction in patients with peritoneal carcinomatosis from appendiceal or colorectal cancer.

Abstract Poster

Authors

null

Aabha Oza

Indiana University, Indianapolis, IN

Aabha Oza , Patrick Grierson , Sean Glasgow , Katrina Pedersen , Stephen Barman , Thomas Westbrook , Matthew G Mutch , Andrea Wang-Gillam , Ashley Morton , Samantha Marquez , James W Fleshman , Benjamin R. Tan Jr., Rama Suresh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01061515

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 746)

DOI

10.1200/JCO.2018.36.4_suppl.746

Abstract #

746

Poster Bd #

J12

Abstract Disclosures

Similar Posters

First Author: Raghav Sundar

First Author: T.R. Jeffry Evans

First Author: Elena Fountzilas

First Author: Sarah Patricia Blagden